Scientists Identify ‘Aurora’ Protein as Vital Traffic Controller for Malaria Parasite Replication and Transmission

University of Nottingham scientists identify ARK1 as the protein malaria needs to divide. Learn how this discovery could block transmission and kill parasites.

By: AXL Media

Published: Feb 26, 2026, 6:39 AM EST

Source: The information in this article was sourced from University of Nottingham

Mapping the Unconventional Division of Plasmodium

The Plasmodium parasite, the causative agent of malaria, remains one of the global healthcare system's most persistent and deadly challenges. Unlike human cells that follow standard mitotic pathways, the malaria parasite utilizes a unique and atypical method of replication to multiply rapidly within its hosts. A new study published in Nature Communications has provided a detailed "blueprint" of this process by identifying Aurora-related kinase 1 (ARK1). This molecule acts as a critical regulator, ensuring that the parasite’s genetic material is correctly organized and distributed during its rapid growth phases.

The Spindle Apparatus: A Molecular Traffic Controller

The research, involving the University of Nottingham and the National Institute of Immunology in India, focused on how the parasite organizes its "spindle"—the complex machinery responsible for pulling genetic material apart. The team discovered that ARK1 serves as a "traffic controller" for these spindles. Without the guidance of ARK1, the molecular machinery fails to form correctly, leading to a total collapse of the parasite’s ability to divide. This discovery is particularly significant because it explains how the parasite manages to replicate so efficiently under the chaotic conditions of a host's bloodstream.

Breaking the Cycle of Transmission

When researchers deactivated the ARK1 protein in laboratory settings, the results were definitive: the parasites could no longer multiply. Crucially, this failure was observed across both stages of the parasite’s life cycle—within the human host and the mosquito. Parasites lacking a functional ARK1 molecule were unable to complete their development in the mosquito's gut, effectively preventing the disease from being transmitted to the next victim. This suggests that a drug targeting ARK1 could act as both a cure for the infected individual and a "transmission blocker" to protect the broader community.